Mouse version of 3q29 deletion: insights into schizophrenia/ASD pathways

Emory researchers see investigating 3q29 deletion as a way of unraveling schizophrenia’s biological and genetic Read more

B cells off the rails early in lupus

Emory scientists could discern that in people with SLE, signals driving expansion and activation are present at an earlier stage of B cell differentiation than previously Read more

Head to head narcolepsy/hypersomnia study

At the sleep research meeting in San Antonio this year, there were signs of an impending pharmaceutical arms race in the realm of narcolepsy. The big fish in a small pond, Jazz Pharmaceuticals, was preparing to market its recently FDA-approved medication: Sunosi/solriamfetol. Startup Harmony Biosciences was close behind with pitolisant, already approved in Europe. On the horizon are experimental drugs designed to more precisely target the neuropeptide deficiency in people with classic narcolepsy type 1 Read more

deltamethrin

Insecticide-ADHD link, with caveats

Gary Miller’s lab at Emory was the launching pad for this study from Rutgers, published last week in the FASEB Journal, showing a potential connection between a common type of insecticide used at home and in agriculture, pyrethroids, and attention deficit hyperactivity disorder (ADHD).  Read more

Posted on by Quinn Eastman in Neuro Leave a comment